hemophilia B
FDA Approves Qfitlia for Hemophilia A or B
The FDA approved Qfitlia for adults and children 12 years of age and older with hemophilia A or B, with or without ...
APRIL 7, 2025
$1 Million Health Plan Savings for Hemophilia Gene Therapy Projected
A gene therapy product approved for adults with hemophilia B may increase initial costs for health plans but can ...
DECEMBER 13, 2024
FDA Approves Idelvion for Hemophilia B
In clinical trials, Idelvion maintained factor IX activity levels above 5% over 14 days, resulting in a median ...
MARCH 8, 2016
Load more